Screening for donor-derived clonal hematopoiesis may have prognostic value for outcomes following auto-HSCT in patients with hematologic malignancies.
Back
Meta-Analysis Reveals Potential Role of Clonal Hematopoiesis on Allogeneic and Autologous SCT Outcomes
Shyam A. Patel, MD, PhD, discusses data from a meta-analysis that explored donor-engrafted clonal hematopoiesis's effects in allogeneic and autologous stem cell transplantation.
Meta-Analysis Reveals Potential Role of Clonal Hematopoiesis on Allogeneic and Autologous SCT Outcomes
Episodes
All
All
Shyam A. Patel, MD, PhD, discusses findings from a meta-analysis of the effect of clonal hematopoiesis on outcomes for hematopoietic stem cell transplant.
Shyam A. Patel, MD, PhD, discusses the impact of donor-engrafted clonal hematopoiesis on the risk of disease relapse and survival outcomes with allo- and auto-HSCT.
Advertisement
Advertisement
Trending on OncLive
1
Revumenib Plus Chemo Yields High Response and MRD-Negativity Rates in Newly Diagnosed NPM1+ or KMT2A+ AML
2
Ofirnoflast Elicits Durable Transfusion Independence, Hematologic Improvement in Lower-Risk MDS
3
ACTIVE Regimen Elicits High Response Rates in R/R NPM1-Mutated AML
4
Dr Gangat on Phase 2 Efficacy and Safety Data for DISC-3405 in Polycythemia Vera
5